Literature DB >> 28114835

Dorsal striatum D1-expressing neurons are involved with sensorimotor gating on prepulse inhibition test.

Samanta Rodrigues1, Cristiane Salum1, Tatiana L Ferreira1.   

Abstract

Prepulse inhibition (PPI) is a behavioral test in which the startle reflex response to a high-intensity stimulus (pulse) is inhibited by the prior presentation of a weak stimulus (prepulse). The classic neural circuitry that mediates startle response is localized in the brainstem; however, recent studies point to the contribution of structures involved in higher cognitive functions in regulating the sensorimotor gating, particularly forebrain regions innervated by dopaminergic nuclei. The aim of the present study was to verify the role of dorsal striatum (DS) and dopaminergic transmitting mediated by D1 and D2 receptors on PPI test in rats. DS inactivation induced by muscimol injection did not affect PPI (%PPI and startle response), although it impaired the locomotor activity and caused catalepsy. Infusion of D1-like antagonist SCH23390 impaired %PPI but did not disturb the startle response and locomotor activity evaluated immediately after PPI test. D2 antagonist microinjection (sulpiride) did not affect %PPI and startle response, but impaired motor activity. These results point to an important role of DS, probably mediated by direct basal ganglia pathway, on modulation of sensorimotor gating, in accordance with clinical studies showing PPI deficits in schizophrenia, Tourette syndrome, and compulsive disorders - pathologies related to basal ganglia dysfunctions.

Entities:  

Keywords:  Dopamine; SCH23390; Wistar rat; muscimol; prepulse inhibition; sulpiride

Mesh:

Substances:

Year:  2017        PMID: 28114835     DOI: 10.1177/0269881116686879

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

1.  Inhibition of the substantia nigra pars reticulata produces divergent effects on sensorimotor gating in rats and monkeys.

Authors:  Brittany L Aguilar; Patrick A Forcelli; Ludise Malkova
Journal:  Sci Rep       Date:  2018-06-19       Impact factor: 4.379

2.  Enhanced Dopamine in Prodromal Schizophrenia (EDiPS): a new animal model of relevance to schizophrenia.

Authors:  Alice Petty; Xiaoying Cui; Yasvir Tesiram; Deniz Kirik; Oliver Howes; Darryl Eyles
Journal:  NPJ Schizophr       Date:  2019-03-29

3.  Disruption of prepulse inhibition is associated with compulsive behavior severity and nucleus accumbens dopamine receptor changes in Sapap3 knockout mice.

Authors:  Elizabeth E Manning; Abigail Y Wang; Linda M Saikali; Anna S Winner; Susanne E Ahmari
Journal:  Sci Rep       Date:  2021-05-03       Impact factor: 4.379

4.  Regulation of sensorimotor gating via Disc1/Huntingtin-mediated Bdnf transport in the cortico-striatal circuit.

Authors:  Hanna Jaaro-Peled; Sunil Kumar; Dalton Hughes; Akiko Sumitomo; Sun-Hong Kim; Sandra Zoubovsky; Yuki Hirota-Tsuyada; Diana Zala; Julie Bruyere; Brittany M Katz; Beverly Huang; Rafael Flores; Soumya Narayan; Zhipeng Hou; Aris N Economides; Takatoshi Hikida; William C Wetsel; Karl Deisseroth; Susumu Mori; Nicholas J Brandon; Motomasa Tanaka; Koko Ishizuka; Miles D Houslay; Frédéric Saudou; Kafui Dzirasa; Akira Sawa; Toshifumi Tomoda
Journal:  Mol Psychiatry       Date:  2022-02-14       Impact factor: 13.437

5.  Anandamide Effects in a Streptozotocin-Induced Alzheimer's Disease-Like Sporadic Dementia in Rats.

Authors:  Daniel Moreira-Silva; Daniel C Carrettiero; Adriele S A Oliveira; Samanta Rodrigues; Joyce Dos Santos-Lopes; Paula M Canas; Rodrigo A Cunha; Maria C Almeida; Tatiana L Ferreira
Journal:  Front Neurosci       Date:  2018-09-21       Impact factor: 4.677

6.  Effects of Chemogenetic Inhibition of D1 or D2 Receptor-Containing Neurons of the Substantia Nigra and Striatum in Mice With Tourette Syndrome.

Authors:  Lixue Lin; Yuye Lan; He Zhu; Lingling Yu; Shuang Wu; Wangyixuan Wan; Yang Shu; Hongchun Xiang; Tengfei Hou; Hong Zhang; Yan Ma; Wen Su; Man Li
Journal:  Front Mol Neurosci       Date:  2021-12-09       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.